Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...
Zacks.com on MSN16h
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock FallsBruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year ...
Hosted on MSN1d
Stocks Muted Before the Open as Investors Await Key U.S. PPI Data and Corporate EarningsS&P 500 E-Mini futures (ESH25) are down -0.02%, andMarch Nasdaq 100 E-Mini futures (NQH25) are up +0.06% this morning as ...
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank H. Laukien, Bruker's ...
Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...
After hours: February 13 at 5:04:50 PM EST Loading Chart for BRKR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback